Over the years, the Pediatric Bone Marrow Transplant Service has acquired experience in transplanting marrow, peripheral blood stem cells, and cord blood stem cells for thousands of patients with many different diseases. Our clinicians have published over one hundred articles in medical journals with important findings about leukemias, lymphomas, and myelodysplastic syndromes, as well as conditions such as sickle cell disease, thalassemia, severe combined immune deficiency (SCID), and aplastic anemia.
The wisdom that comes from seeing so many patients grow into healthy adulthood after treatment for life-threatening illnesses.
Many members of Memorial Sloan Kettering Cancer Center's transplantation team have worked at the Center for more than a decade, acquiring vast professional and personal experience in managing serious diseases with care that is aggressive and appropriate — resulting in some of the best outcomes in the United States and worldwide.
A commitment to avoiding complications, and the biomedical resources to change the odds.
Graft-versus-host disease (GvHD) is one of the worst and most common complications of transplantation. The risk for GvHD in the young, although lower than that of older patients, is still significant — especially when transplants must come from unrelated donors. Our physicians developed immune-cell depletion and other transplant-preparative regimens for some of the lowest GvHD rates in the United States, and are dedicated to getting rid of GvHD altogether. MSK's Long-Term Follow-Up Program provides leading-edge surveillance and therapeutic interventions for years after treatment.